Millennium Management’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.94M | Buy |
323,553
+261,671
| +423% | +$3M | ﹤0.01% | 2746 |
|
|
2025
Q4 | $734K | Buy |
+61,882
| New | +$788K | ﹤0.01% | 4690 |
|
|
2025
Q2 | – | Sell |
-139
| Closed | -$2.91K | – | 6097 |
|
|
2025
Q1 | $2.91K | Sell |
139
-5
| -3% | -$134 | ﹤0.01% | 5738 |
|
|
2024
Q4 | $3.59K | Sell |
144
-45
| -24% | -$1.23K | ﹤0.01% | 5829 |
|
|
2024
Q3 | $3.19K | Sell |
189
-1,673
| -90% | -$35.1K | ﹤0.01% | 5951 |
|
|
2024
Q2 | $52.4K | Sell |
1,862
-5,608
| -75% | -$583K | ﹤0.01% | 5409 |
|
|
2024
Q1 | $2.24M | Buy |
7,470
+7,081
| +1,820% | +$2.12M | ﹤0.01% | 3636 |
|
|
2023
Q4 | $91.8K | Sell |
389
-250
| -39% | -$38.9K | ﹤0.01% | 5367 |
|
|
2023
Q3 | $95.8K | Sell |
639
-139
| -18% | -$21.9K | ﹤0.01% | 5352 |
|
|
2023
Q2 | $135K | Sell |
778
-4,120
| -84% | -$691K | ﹤0.01% | 5252 |
|
|
2023
Q1 | $617K | Sell |
4,898
-4,331
| -47% | -$975K | ﹤0.01% | 4470 |
|
|
2022
Q4 | $2.8M | Buy |
9,229
+5,566
| +152% | +$821K | ﹤0.01% | 3280 |
|
|
2022
Q3 | $202K | Sell |
3,663
-684
| -16% | -$49.2K | ﹤0.01% | 5656 |
|
|
2022
Q2 | $260K | Buy |
4,347
+305
| +8% | +$22.6K | ﹤0.01% | 5475 |
|
|
2022
Q1 | $461K | Sell |
4,042
-2,875
| -42% | -$337K | ﹤0.01% | 5188 |
|
|
2021
Q4 | $996K | Buy |
6,917
+2,437
| +54% | +$442K | ﹤0.01% | 4418 |
|
|
2021
Q3 | $981K | Sell |
4,480
-2,386
| -35% | -$505K | ﹤0.01% | 4711 |
|
|
2021
Q2 | $1.59M | Buy |
6,866
+6,370
| +1,284% | +$1.62M | ﹤0.01% | 4213 |
|
|
2021
Q1 | $149K | Sell |
496
-1,729
| -78% | -$619K | ﹤0.01% | 5591 |
|
|
2020
Q4 | $837K | Buy |
+2,225
| New | +$780K | ﹤0.01% | 3846 |
|
|
2020
Q3 | – | Sell |
-1,318
| Closed | -$496K | – | 4592 |
|
|
2020
Q2 | $496K | Buy |
1,318
+260
| +25% | +$73.6K | ﹤0.01% | 3406 |
|
|
2020
Q1 | $241K | Buy |
1,058
+276
| +35% | +$105K | ﹤0.01% | 3294 |
|
|
2019
Q4 | $414K | Sell |
782
-1,532
| -66% | -$829K | ﹤0.01% | 3492 |
|
|
2019
Q3 | $997K | Buy |
2,314
+1,978
| +589% | +$1.27M | ﹤0.01% | 2858 |
|
|
2019
Q2 | $400K | Buy |
336
+153
| +84% | +$183K | ﹤0.01% | 3374 |
|
|
2019
Q1 | $228K | Sell |
183
-51
| -22% | -$58.4K | ﹤0.01% | 3681 |
|
|
2018
Q4 | $222K | Buy |
+234
| New | +$282K | ﹤0.01% | 3360 |
|
|
2018
Q3 | – | Sell |
-1,312
| Closed | -$2.12M | – | 4042 |
|
|
2018
Q2 | $2.12M | Sell |
1,312
-1,054
| -45% | -$1.81M | ﹤0.01% | 2357 |
|
|
2018
Q1 | $3.84M | Buy |
2,366
+2,234
| +1,692% | +$4.65M | 0.01% | 1961 |
|
|
2017
Q4 | $221K | Sell |
132
-6,718
| -98% | -$8.88M | ﹤0.01% | 3487 |
|
|
2017
Q3 | $9.58M | Sell |
6,850
-6,919
| -50% | -$8.12M | 0.02% | 1278 |
|
|
2017
Q2 | $15.4M | Buy |
13,769
+13,331
| +3,044% | +$11M | 0.03% | 806 |
|
|
2017
Q1 | $238K | Sell |
438
-70
| -14% | -$43K | ﹤0.01% | 3141 |
|
|
2016
Q4 | $310K | Buy |
+508
| New | +$317K | ﹤0.01% | 2878 |
|
|
2014
Q3 | – | Sell |
-136
| Closed | -$115K | – | 3807 |
|
|
2014
Q2 | $115K | Buy |
+136
| New | +$135K | ﹤0.01% | 3240 |
|
Other funds holding CBIO
BI
FFM
VA
FIS
VPC
OM
TCM
VCM